Loading…
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
98pct
614d open
vs 10,564 other HR bills in the 118th — cohort avg 68d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (6)
2025 · first_quarter · Health Issues
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Ways and Means, Agriculture, and Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
H.Con.Res.14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034, provisions related to recommendations of changes in laws within the jurisdiction of the Senate Finance Committee and House Energy and Commerce Committee S.Con.Res.7- An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034, provisions related to the recommendations of changes in laws within the jurisdiction of the Senate Finance Committee and House Energy and Commerce Committee H.R. 869/S.343, Keep Our PACT Act, all provisions H.R. 1436/S.627, ENABLE Act, all provisions H.R. 1520, CharlotteWoodwardOrgan Transplant Discrimination Prevention Act, all provisions H.R. 1570/S.745, EmpoweringFamiliesin Special Education Act, all provisions H.R. 1621, Entrepreneurs with Disabilities Reporting Act of 2025, all provisions H.R. 1634, ThinkDIFFERENTLY About Disability Employment Act, all provisions H.R. 1757/S.73, EMPSA Act, all provisions H.R.1968 - Full-Year Continuing Appropriations and Extensions Act, 2025, provision related to funding of the congressionally directed medical research program H.R. 2036/S. 925, CreditforCaring Act of 2025, all provisions H.R. 2491/S.1227, ABC Act, all provisions H.R. 2540/S.1234, SSI Savings Penalty Elimination Act, all provisions H.R. 2560/S.830, Lifespan Respite Care Reauthorization Act of 2025, all provisions H.R. 2598/S.1277, IDEA Full Funding Act, all provisions Implementation of Public Law 118-80, Autism CARES Act of 2024, all provisions A bill not yet introduced to enhance incentives to create accessible and inclusive workplaces A bill not yet introduced to increase housing opportunities for people with disabilities A reconciliation bill not yet introduced, provisions related to Medicaid A bill not introduced related to Fiscal Year 2026 appropriations by the House, provisions related to funding autism research and services at the National Institutes of Health, Centers for Disease Control and Prevention, Health Resources and Services Administration; assistive technology programs and special education at the Department of Education; funding for the Kevin and Avonte's Law Program; and the congressionally directed medical research autism research program A bill not introduced related to Fiscal Year 2026 appropriations by the Senate, provisions related to funding autism research and services at the National Institutes of Health, Centers for Disease Control and Prevention, Health Resources and Services Administration; assistive technology programs and special education at the Department of Education; funding for the Kevin and Avonte's Law Program; and the congressionally directed medical research autism research program A bill not yet introduced to designate individuals with intellectual and developmental disabilities as a medically underserved population
Client expense: $30,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Alcohol and Drug Abuse
**Issues lobbied without specific bill number: Marijuana Research H.R. 2598 Marijuana Regulation H.R. 3829 Marijuana Research
Client expense: $1,140,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Alcohol and Drug Abuse
H.R.610 - To provide for the rescheduling of marijuana into schedule III of the Controlled Substances Act. (Greg Steube, R-FL-17) H.R.2598 - To establish a Commission on the Federal Regulation of Cannabis to study a prompt and plausible pathway to the Federal regulation of cannabis, and for other purposes. (David Joyce, R-OH-14) Senate Version: S.2650 - A bill to establish a Commission on the Federal Regulation of Cannabis to study a prompt and plausible pathway to the Federal regulation of cannabis, and for other purposes. (John Hickenlooper, D-CO) H.R.3829 - To streamline the process for institutions of higher education to research marijuana. (Dina Titus, D-NV-1) S.2909 - A bill to provide for congressional review of rules rescheduling marijuana. (Cynthia Lummis, R-WY) H.R.6028 - To amend the Controlled Substances Act regarding marihuana, and for other purposes. (Nancy Mace, R-SC-1) H.R.6673 - To amend the Controlled Substances Act to provide for a new rule regarding the application of the Act to marijuana, and for other purposes. (Dave Joyce, R-OH-14)
Client expense: $400,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Consumer Issues/Safety/Products
Cannabis Policy Issues; Prepare Act, H.R. 2598
Client expense: $100,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Alcohol and Drug Abuse
**Issues lobbied without specific bill number: Marijuana Research H.R. 2598 Marijuana Regulation H.R. 3829 Marijuana Research
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Alcohol and Drug Abuse
H.R.610 - To provide for the rescheduling of marijuana into schedule III of the Controlled Substances Act. (Greg Steube, R-FL-17) H.R.2598 - To establish a Commission on the Federal Regulation of Cannabis to study a prompt and plausible pathway to the Federal regulation of cannabis, and for other purposes. (David Joyce, R-OH-14) Senate Version: S.2650 - A bill to establish a Commission on the Federal Regulation of Cannabis to study a prompt and plausible pathway to the Federal regulation of cannabis, and for other purposes. (John Hickenlooper, D-CO) H.R.3829 - To streamline the process for institutions of higher education to research marijuana. (Dina Titus, D-NV-1) S.2909 - A bill to provide for congressional review of rules rescheduling marijuana. (Cynthia Lummis, R-WY) H.R.6028 - To amend the Controlled Substances Act regarding marihuana, and for other purposes. (Nancy Mace, R-SC-1) H.R.6673 - To amend the Controlled Substances Act to provide for a new rule regarding the application of the Act to marijuana, and for other purposes. (Dave Joyce, R-OH-14)
Client expense: $440,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Alcohol and Drug Abuse
**Issues lobbied without specific bill number: Marijuana Research H.R. 2598 Marijuana Regulation H.R. 3829 Marijuana Research
Client expense: $1,370,000 · Firm income: Not reported
2024 · third_quarter · Alcohol and Drug Abuse
H.R.610 - To provide for the rescheduling of marijuana into schedule III of the Controlled Substances Act. (Greg Steube, R-FL-17) H.R.2598 - To establish a Commission on the Federal Regulation of Cannabis to study a prompt and plausible pathway to the Federal regulation of cannabis, and for other purposes. (David Joyce, R-OH-14) Senate Version: S.2650 - A bill to establish a Commission on the Federal Regulation of Cannabis to study a prompt and plausible pathway to the Federal regulation of cannabis, and for other purposes. (John Hickenlooper, D-CO) H.R.3829 - To streamline the process for institutions of higher education to research marijuana. (Dina Titus, D-NV-1) S.2909 - A bill to provide for congressional review of rules rescheduling marijuana. (Cynthia Lummis, R-WY) H.R.6028 - To amend the Controlled Substances Act regarding marihuana, and for other purposes. (Nancy Mace, R-SC-1) H.R.6673 - To amend the Controlled Substances Act to provide for a new rule regarding the application of the Act to marijuana, and for other purposes. (Dave Joyce, R-OH-14)
Client expense: $440,000 · Firm income: Not reported
2024 · third_quarter · Alcohol and Drug Abuse
**Issues lobbied without specific bill number: Marijuana Research H.R. 2598 Marijuana Regulation H.R. 3829 Marijuana Research
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Consumer Issues/Safety/Products
Cannabis Policy Issues; Prepare Act, H.R. 2598
Client expense: $84,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Alcohol and Drug Abuse
H.R.610 - To provide for the rescheduling of marijuana into schedule III of the Controlled Substances Act. (Greg Steube, R-FL-17) H.R.2598 - To establish a Commission on the Federal Regulation of Cannabis to study a prompt and plausible pathway to the Federal regulation of cannabis, and for other purposes. (David Joyce, R-OH-14) Senate Version: S.2650 - A bill to establish a Commission on the Federal Regulation of Cannabis to study a prompt and plausible pathway to the Federal regulation of cannabis, and for other purposes. (John Hickenlooper, D-CO) H.R.3829 - To streamline the process for institutions of higher education to research marijuana. (Dina Titus, D-NV-1) S.2909 - A bill to provide for congressional review of rules rescheduling marijuana. (Cynthia Lummis, R-WY) H.R.6028 - To amend the Controlled Substances Act regarding marihuana, and for other purposes. (Nancy Mace, R-SC-1) H.R.6673 - To amend the Controlled Substances Act to provide for a new rule regarding the application of the Act to marijuana, and for other purposes. (Dave Joyce, R-OH-14)
Client expense: $450,000 · Firm income: Not reported
2024 · second_quarter · Consumer Issues/Safety/Products
Cannabis Policy Issues; Prepare Act, H.R. 2598
Client expense: $100,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Alcohol and Drug Abuse
**Issues lobbied without specific bill number: Marijuana Research H.R. 2598 Marijuana Regulation H.R. 3829 Marijuana Research
Client expense: $1,600,000 · Firm income: Not reported
2024 · second_quarter · Alcohol and Drug Abuse
**Issues lobbied without specific bill number: Marijuana Research H.R. 2598 Marijuana Regulation H.R. 3829 Marijuana Research
Client expense: Not reported · Firm income: $44,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Consumer Issues/Safety/Products
Cannabis Policy Issues; Prepare Act, H.R. 2598
Client expense: $125,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Alcohol and Drug Abuse
H.R.610 - To provide for the rescheduling of marijuana into schedule III of the Controlled Substances Act. (Greg Steube, R-FL-17) H.R.2598 - To establish a Commission on the Federal Regulation of Cannabis to study a prompt and plausible pathway to the Federal regulation of cannabis, and for other purposes. (David Joyce, R-OH-14) Senate Version: S.2650 - A bill to establish a Commission on the Federal Regulation of Cannabis to study a prompt and plausible pathway to the Federal regulation of cannabis, and for other purposes. (John Hickenlooper, D-CO) H.R.3829 - To streamline the process for institutions of higher education to research marijuana. (Dina Titus, D-NV-1) S.2909 - A bill to provide for congressional review of rules rescheduling marijuana. (Cynthia Lummis, R-WY) H.R.6028 - To amend the Controlled Substances Act regarding marihuana, and for other purposes. (Nancy Mace, R-SC-1) H.R.6673 - To amend the Controlled Substances Act to provide for a new rule regarding the application of the Act to marijuana, and for other purposes. (Dave Joyce, R-OH-14)
Client expense: $380,000 · Firm income: Not reported
2024 · first_quarter · Alcohol and Drug Abuse
**Issues lobbied without specific bill number: Marijuana Research H.R. 2598 Marijuana Regulation H.R. 3829 Marijuana Research
Client expense: $1,490,000 · Firm income: Not reported
2024 · first_quarter · Alcohol and Drug Abuse
**Issues lobbied without specific bill number: Marijuana Research H.R. 2598 Marijuana Regulation H.R. 3829 Marijuana Research
Client expense: Not reported · Firm income: $44,000
2023 · fourth_quarter · Consumer Issues/Safety/Products
Cannabis Policy Issues; Prepare Act, H.R. 2598
Client expense: $210,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · fourth_quarter · Alcohol and Drug Abuse
**Issues lobbied without specific bill number: Marijuana Research H.R. 2598 Marijuana Regulation H.R. 3829 Marijuana Research
Client expense: $1,360,000 · Firm income: Not reported
2023 · fourth_quarter · Alcohol and Drug Abuse
H.R.610 - To provide for the rescheduling of marijuana into schedule III of the Controlled Substances Act. (Greg Steube, R-FL-17) H.R.2598 - To establish a Commission on the Federal Regulation of Cannabis to study a prompt and plausible pathway to the Federal regulation of cannabis, and for other purposes. (David Joyce, R-OH-14) Senate Version: S.2650 - A bill to establish a Commission on the Federal Regulation of Cannabis to study a prompt and plausible pathway to the Federal regulation of cannabis, and for other purposes. (John Hickenlooper, D-CO) H.R.3829 - To streamline the process for institutions of higher education to research marijuana. (Dina Titus, D-NV-1) S.2909 - A bill to provide for congressional review of rules rescheduling marijuana. (Cynthia Lummis, R-WY) H.R.6028 - To amend the Controlled Substances Act regarding marihuana, and for other purposes. (Nancy Mace, R-SC-1) H.R.6673 - To amend the Controlled Substances Act to provide for a new rule regarding the application of the Act to marijuana, and for other purposes. (Dave Joyce, R-OH-14)
Client expense: $410,000 · Firm income: Not reported
2023 · fourth_quarter · Alcohol and Drug Abuse
**Issues lobbied without specific bill number: Marijuana Research H.R. 2598 Marijuana Regulation H.R. 3829 Marijuana Research
Client expense: Not reported · Firm income: $44,000
2023 · third_quarter · Consumer Issues/Safety/Products
Cannabis Policy Issues; Prepare Act, H.R. 2598
Client expense: $210,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · third_quarter · Alcohol and Drug Abuse
H.R.610 - To provide for the rescheduling of marijuana into schedule III of the Controlled Substances Act. (Greg Steube, R-FL-17) H.R.2598 - To establish a Commission on the Federal Regulation of Cannabis to study a prompt and plausible pathway to the Federal regulation of cannabis, and for other purposes. (David Joyce, R-OH-14) Senate Version: S.2650 - A bill to establish a Commission on the Federal Regulation of Cannabis to study a prompt and plausible pathway to the Federal regulation of cannabis, and for other purposes. (John Hickenlooper, D-CO) H.R.3829 - To streamline the process for institutions of higher education to research marijuana. (Dina Titus, D-NV-1) S.2909 - A bill to provide for congressional review of rules rescheduling marijuana. (Cynthia Lummis, R-WY)
Client expense: $440,000 · Firm income: Not reported
2023 · third_quarter · Alcohol and Drug Abuse
**Issues lobbied without specific bill number: Marijuana Research H.R. 2598 Marijuana Regulation H.R. 3829 Marijuana Research
Client expense: $1,490,000 · Firm income: Not reported
2023 · third_quarter · Alcohol and Drug Abuse
**Issues lobbied without specific bill number: Marijuana Research H.R. 2598 Marijuana Regulation H.R. 3829 Marijuana Research
Client expense: Not reported · Firm income: $44,000
2023 · second_quarter · Consumer Issues/Safety/Products
Cannabis Policy Issues; Prepare Act, H.R. 2598
Client expense: $190,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · second_quarter · Alcohol and Drug Abuse
H.R.610 - To provide for the rescheduling of marijuana into schedule III of the Controlled Substances Act. (Greg Steube, R-FL-17) H.R.2598 - To establish a Commission on the Federal Regulation of Cannabis to study a prompt and plausible pathway to the Federal regulation of cannabis, and for other purposes. (David Joyce, R-OH-14) H.R.3829 - To streamline the process for institutions of higher education to research marijuana. (Dina Titus, D-NV-1)
Client expense: $450,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · second_quarter · Alcohol and Drug Abuse
**Issues lobbied without specific bill number: Marijuana Research H.R. 2598 Marijuana Regulation H.R. 3829 Marijuana Research
Client expense: $1,700,000 · Firm income: Not reported
2023 · second_quarter · Alcohol and Drug Abuse
**Issues lobbied without specific bill number: Marijuana Research H.R. 2598 Marijuana Regulation H.R. 3829 Marijuana Research
Client expense: Not reported · Firm income: $44,520
2023 · second_quarter · Government Issues
As the federal government considers how to reconcile state legal cannabis programs with cannabis' federal illegality, the National Cannabis Roundtable supports legislation and regulatory paradigms that decriminalize cannabis, remediate the harm of the failed War on Drugs, ensure the highest standards of consumer safety, respect existing cannabis supply chains and provide equitable financial treatment for cannabis businesses. NCR also supported the reintroduction of the PREPARE Act (HR 2598), which directs federal agencies as to best practices and regulations upon federal legalization.
Client expense: Not reported · Firm income: $20,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2023 · first_quarter · Government Issues
As the federal government considers how to reconcile state legal cannabis programs with cannabis' federal illegality, the National Cannabis Roundtable supports legislation and regulatory paradigms that decriminalize cannabis, remediate the harm of the failed War on Drugs, ensure the highest standards of consumer safety, respect existing cannabis supply chains and provide equitable financial treatment for cannabis businesses. NCR also supported the reintroduction of the PREPARE Act (HR 2598), which directs federal agencies as to best practices and regulations upon federal legalization.
Client expense: Not reported · Firm income: $20,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2023 · first_quarter · Government Issues
As the federal government considers how to reconcile state legal cannabis programs with cannabis' federal illegality, the National Cannabis Roundtable supports legislation and regulatory paradigms that decriminalize cannabis, remediate the harm of the failed War on Drugs, ensure the highest standards of consumer safety, respect existing cannabis supply chains and provide equitable financial treatment for cannabis businesses. NCR also supported the reintroduction of the PREPARE Act (HR 2598), which directs federal agencies as to best practices and regulations upon federal legalization.
Client expense: Not reported · Firm income: $20,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
| Referred To |
| April 13, 2023 |
| Judiciary Committee | House | Referred To | April 13, 2023 |
| Republican |
| OH |
| Troy A. Carter | Democratic | LA |
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE